Erdheim-Chester disease: imaging-guided therapeutic approach.

Emanuel Della Torre, Lorenzo Dagna, Paola Mapelli, Renata Mellone, Maria Grazia Sabbadini

Research output: Contribution to journalArticle

Abstract

Erdheim-Chester disease (ECD) is a rare form of systemic non-Langerhans cell histiocytosis with characteristic bone involvement. However, extraskeletal involvement occurs in approximately half of the patients. Because of its protean findings, the diagnosis of ECD is often delayed; thus, a clinical suspicion may prompt specific imaging studies to recognize suggestive signs of organ involvement. In this study, a case of a patient with ECD with representative progressive multisystemic involvement has been reported; although the final diagnosis was confirmed by histologic analysis, imaging studies with almost pathognomonic findings guided the diagnostic process and prompted different therapeutic approaches according to the localization of the disease.

Original languageEnglish
Pages (from-to)704-706
Number of pages3
JournalClinical Nuclear Medicine
Volume36
Issue number8
Publication statusPublished - Aug 2011

Fingerprint

Erdheim-Chester Disease
Non-Langerhans-Cell Histiocytosis
Therapeutics
Bone and Bones

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Della Torre, E., Dagna, L., Mapelli, P., Mellone, R., & Grazia Sabbadini, M. (2011). Erdheim-Chester disease: imaging-guided therapeutic approach. Clinical Nuclear Medicine, 36(8), 704-706.

Erdheim-Chester disease : imaging-guided therapeutic approach. / Della Torre, Emanuel; Dagna, Lorenzo; Mapelli, Paola; Mellone, Renata; Grazia Sabbadini, Maria.

In: Clinical Nuclear Medicine, Vol. 36, No. 8, 08.2011, p. 704-706.

Research output: Contribution to journalArticle

Della Torre, E, Dagna, L, Mapelli, P, Mellone, R & Grazia Sabbadini, M 2011, 'Erdheim-Chester disease: imaging-guided therapeutic approach.', Clinical Nuclear Medicine, vol. 36, no. 8, pp. 704-706.
Della Torre E, Dagna L, Mapelli P, Mellone R, Grazia Sabbadini M. Erdheim-Chester disease: imaging-guided therapeutic approach. Clinical Nuclear Medicine. 2011 Aug;36(8):704-706.
Della Torre, Emanuel ; Dagna, Lorenzo ; Mapelli, Paola ; Mellone, Renata ; Grazia Sabbadini, Maria. / Erdheim-Chester disease : imaging-guided therapeutic approach. In: Clinical Nuclear Medicine. 2011 ; Vol. 36, No. 8. pp. 704-706.
@article{4762a09abdbb432888fbc95725a1726e,
title = "Erdheim-Chester disease: imaging-guided therapeutic approach.",
abstract = "Erdheim-Chester disease (ECD) is a rare form of systemic non-Langerhans cell histiocytosis with characteristic bone involvement. However, extraskeletal involvement occurs in approximately half of the patients. Because of its protean findings, the diagnosis of ECD is often delayed; thus, a clinical suspicion may prompt specific imaging studies to recognize suggestive signs of organ involvement. In this study, a case of a patient with ECD with representative progressive multisystemic involvement has been reported; although the final diagnosis was confirmed by histologic analysis, imaging studies with almost pathognomonic findings guided the diagnostic process and prompted different therapeutic approaches according to the localization of the disease.",
author = "{Della Torre}, Emanuel and Lorenzo Dagna and Paola Mapelli and Renata Mellone and {Grazia Sabbadini}, Maria",
year = "2011",
month = "8",
language = "English",
volume = "36",
pages = "704--706",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Erdheim-Chester disease

T2 - imaging-guided therapeutic approach.

AU - Della Torre, Emanuel

AU - Dagna, Lorenzo

AU - Mapelli, Paola

AU - Mellone, Renata

AU - Grazia Sabbadini, Maria

PY - 2011/8

Y1 - 2011/8

N2 - Erdheim-Chester disease (ECD) is a rare form of systemic non-Langerhans cell histiocytosis with characteristic bone involvement. However, extraskeletal involvement occurs in approximately half of the patients. Because of its protean findings, the diagnosis of ECD is often delayed; thus, a clinical suspicion may prompt specific imaging studies to recognize suggestive signs of organ involvement. In this study, a case of a patient with ECD with representative progressive multisystemic involvement has been reported; although the final diagnosis was confirmed by histologic analysis, imaging studies with almost pathognomonic findings guided the diagnostic process and prompted different therapeutic approaches according to the localization of the disease.

AB - Erdheim-Chester disease (ECD) is a rare form of systemic non-Langerhans cell histiocytosis with characteristic bone involvement. However, extraskeletal involvement occurs in approximately half of the patients. Because of its protean findings, the diagnosis of ECD is often delayed; thus, a clinical suspicion may prompt specific imaging studies to recognize suggestive signs of organ involvement. In this study, a case of a patient with ECD with representative progressive multisystemic involvement has been reported; although the final diagnosis was confirmed by histologic analysis, imaging studies with almost pathognomonic findings guided the diagnostic process and prompted different therapeutic approaches according to the localization of the disease.

UR - http://www.scopus.com/inward/record.url?scp=80054787366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054787366&partnerID=8YFLogxK

M3 - Article

C2 - 21716027

AN - SCOPUS:80054787366

VL - 36

SP - 704

EP - 706

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 8

ER -